Waft Pharma Private Limited - pharma in Rajamahendravaram, Andhra Pradesh, India. FY 2026 financials & compliance.
CIN U33100AP2017PTC106922 Incorporated 26 October 2017 ROC Vijayawada HQ Rajamahendravaram, Andhra Pradesh, India
Active Private Limited Company pharma
Revenue · FY 2022
₹30.37 Lakh
▲ 4519% YoY
Net loss · FY 2022
₹3.19 Lakh
Net margin -10.5%
EBITDA · FY 2022
-₹3.11 Lakh
EBITDA margin -10.2%
Authorised capital
₹20 Lakh
Registered with MCA
Paid-up capital
₹20 Lakh
Issued & subscribed
Company age
9 yrs
Est. 2017
Directors on board
5
As per MCA filings
Active GSTINs
1
GST registered

About Waft Pharma Private Limited

Data last updated:

Waft Pharma Private Limited is a private limited company based in Rajamahendravaram, Andhra Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 26 October 2017 and has been in existence for over 9 years.

The company is registered with the Registrar of Companies (ROC), Vijayawada, under CIN U33100AP2017PTC106922. Its GSTIN is 37AACCW0957B1ZH (Andhra Pradesh).

The company has an authorised share capital of ₹20 Lakh and a paid-up capital of ₹20 Lakh. It is led by directors including Venkata Subbarao Gidugu and Venkata Ramaiah Tumati.

Its last annual general meeting (AGM) was held on 30 September 2022, and its latest financial statements are for the year ended 31 March 2022. The registered office is at Rajamahendravaram, Andhra Pradesh.

As per the financials filed for FY 2022, the company reported a revenue of ₹30.37 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹3.19 Lakh (net margin -10.5%) and EBITDA of -₹3.11 Lakh (EBITDA margin -10.2%). Revenue has grown at a compounded annual rate (CAGR) of 26% over three years.

The company is associated with 1 brand: WAFT Pharma.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website waftpharma.com.

Company details

CIN U33100AP2017PTC106922
Registration Number 106922
Incorporation Date 26 October 2017
ROC Vijayawada
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant

Contact details

Waft Pharma Private Limited's registered office is in Rajamahendravaram, Andhra Pradesh. Its website is waftpharma.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    74 – 2 – 5/1 1st Floor Opposite Niveditha Kishore Public School Addepalli Colony Ava Roa, D, Rajamahendravaram, Andhra Pradesh, India – 533103
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Waft Pharma Private Limited, buy the company report.

Comprehensive company report
Waft Pharma Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Waft Pharma operates one associated brand: WAFT Pharma. Each brand links to its own profile.

BrandDescriptionWebsite
Develops and manufactures a range of pharmaceutical products, including tablets, capsules, syrups, liquids, ointments, and injections.waftpharma.com

Business activity

The main business activity of Waft Pharma is hospital and medical care. In detail, this covers other hospital and medical care activities.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
QHospital and Medical CareQ6Other Hospital and Medical Care Activities

To see the full business activity and turnover split of Waft Pharma Private Limited, buy the company report.

Financials of Waft Pharma Private Limited

FY 2022 filings available

Waft Pharma Private Limited reported revenue of ₹30.37 Lakh (up 4519% YoY) for FY 2022.

Revenue · FY 2022
₹30.37 Lakh ▲ 4519%
Net loss · FY 2022
₹3.19 Lakh margin -10.5%
EBITDA · FY 2022
-₹3.11 Lakh margin -10.2%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
3 years · compounded
▲ 26%
EBITDA CAGR growth
1 year
▲ 90%
3 years · compounded
▲ 7%

Revenue has grown at a compounded annual rate (CAGR) of 26% over three years. EBITDA rose 90% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2021-22FY 2020-21FY 2019-20FY 2018-19FY 2017-18
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA-₹3.11 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹3.19 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2021-22FY 2020-21FY 2019-20FY 2018-19FY 2017-18
Profitability
EBITDA Margin-10.2%
Net Profit Margin-10.5%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Waft Pharma Private Limited, buy the company report.

Board of directors of Waft Pharma Private Limited

Waft Pharma has 5 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Venkata Subbarao GiduguDirector21 Oct 20206 Years 0 MonthsCurrent
Venkata Ramaiah TumatiDirector31 Mar 20188 Years 7 MonthsCurrent
Surya Chandra Sekhara Rao SamsaniDirector26 Oct 20179 Years 0 MonthsCurrent
Sai Dileep ViswanadhaDirector26 Oct 20179 Years 0 MonthsCurrent
Santhi Sree TumatiDirector26 Oct 20179 Years 0 MonthsCurrent

Shareholding

The shareholding of Waft Pharma Private Limited is on record for FY 2019, split between promoters, domestic institutions, public shareholders and others.

Shareholder categoryFY 2019
Promoters
Domestic institutional investors (DII)
Public
Others

To see the full shareholding pattern of Waft Pharma Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Waft Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Waft Pharma has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
37AACCW0957B1ZHAndhra PradeshActive07 Dec 2017

To see the full GST registrations and return filing status of Waft Pharma Private Limited, buy the company report.

Recent activity

Waft Pharma Private Limited has 7 board changes on record since 2017: 5 appointments and 2 cessations. The latest: Venkata Subbarao Gidugu was appointed as Director on 21 Oct 2020.

AGM
Waft Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2022 as per latest MCA records.
Filing
Waft Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Vijayawada.
Appointed
Venkata Subbarao Gidugu was appointed as Director.
Ceased
Bala Sadasivuni ceased to be Director.
Ceased
Sudhakar Seetamraju ceased to be Director.
Appointed
Venkata Ramaiah Tumati was appointed as Director.
Appointed
Sai Dileep Viswanadha was appointed as Director.
Appointed
Santhi Sree Tumati was appointed as Director.
Appointed
Surya Chandra Sekhara Rao Samsani was appointed as Director.
Incorporation
26 Oct 2017
Waft Pharma Private Limited was registered on 26 Oct 2017 with Roc Vijayawada & aged 9 years 25 days as per MCA records.

Frequently asked questions

Waft Pharma is an active private limited company based in Rajamahendravaram, Andhra Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 26 October 2017 (9+ years old) and is registered under CIN U33100AP2017PTC106922.

Waft Pharma has 5 current directors:

The latest financial statements of Waft Pharma on record with the MCA are for the year ended 31 March 2022. Its last annual general meeting was held on 30 September 2022. Year-wise statements from FY 2018 are in the company report.

The GSTIN of Waft Pharma is 37AACCW0957B1ZH, registered in Andhra Pradesh.

The CIN (Corporate Identification Number) of Waft Pharma is U33100AP2017PTC106922. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Waft Pharma was incorporated on 26 October 2017, making it 9+ years old. It is registered with the Registrar of Companies, Vijayawada.

Venkata Subbarao Gidugu was appointed as Director on 21 Oct 2020. Bala Sadasivuni ceased to be Director on 31 Mar 2018. Sudhakar Seetamraju ceased to be Director on 31 Mar 2018. Waft Pharma has 7 board changes on record in total.

Waft Pharma can be reached through the website waftpharma.com. Its registered office is in Rajamahendravaram, Andhra Pradesh, India.

The registered office of Waft Pharma is at 74 – 2 – 51 1st Floor Opposite Niveditha Kishore Public School Addepalli Colony Ava Roa, D, Rajamahendravaram, Andhra Pradesh, India – 533103.

Waft Pharma operates in the pharma industry, in the drug formulation and development segment.